Literature DB >> 7423418

[Epidemiological aspects of the encephalopathies resulting from oral administration of bismuth (author's transl)].

G Martin-Bouyer, B Foulon, H Guerbois, C Barin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7423418

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  3 in total

1.  Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).

Authors:  L F Lacey; N M Frazer; O N Keene; J T Smith
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

2.  Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure.

Authors:  R J Playford; C H Matthews; M J Campbell; H T Delves; K K Hla; H J Hodgson; J Calam
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

Review 3.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.